FindTrial
Sign In

Study of the effects of Lingzhi therapy on cardiovascular, metabolic, antioxidant and inflammation parameters

Study of the effects of Lingzhi therapy on cardiovascular, metabolic, antioxidant and inflammation parameters

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000654
Enrollment
Unknown
Registered
2005-09-12
Start date
2001-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart and Blood Vessel Diseases

Interventions

Two groups:Lingzhi capsule 32 weeks versus placebo

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with mild hypertension

Exclusion criteria

Exclusion criteria: Patients with recent ischemic events

Design outcomes

Primary

MeasureTime frame
Changes in blood pressure and plasma lipid;—

Secondary

MeasureTime frame
Changes in plasma antioxidant status, markers of inflammation and endothelial function.;—

Countries

China

Contacts

Public ContactBrian Tomlinson
www.na@163.com+852 26323139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026